Karel Petrak
Keine laufenden Positionen mehr
Profil
Karel Petrak is Vice President of Research and Development for Agennix, Inc. He joined the company in January, 2001.
Prior to Agennix, he was a Director of GeneMedicine, Inc. and Lavipharm.
Before that, he worked for CIBA-Geigy AG and Novartis AG.
Mr. Petrak received an Engineering degree and a Master of Science degree in Macromolecular Science from the Czech Technical University as well as a PhD from the University of Sussex.
Ehemalige bekannte Positionen von Karel Petrak
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Corporate Officer/Principal | - |
gMed., Inc.
 gMed., Inc. BiotechnologyHealth Technology gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL. | Direktor/Vorstandsmitglied | - |
Lavipharm Corp.
 Lavipharm Corp. Pharmaceuticals: MajorHealth Technology Lavipharm Corp. manufactures and distributes pharmaceutical and cosmetic products. It develops drugs for the cardiology, central nervous system, gastrointestinal system, and dermatological treatment. The company was founded in 1979 and is located in East Windsor, NJ. | Direktor/Vorstandsmitglied | - |
Agennix, Inc.
 Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Karel Petrak
| Czech Technical University | Graduate Degree |
| University of Sussex | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Agennix, Inc.
Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Health Technology |
gMed., Inc.
gMed., Inc. BiotechnologyHealth Technology gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL. | Health Technology |
Lavipharm Corp.
Lavipharm Corp. Pharmaceuticals: MajorHealth Technology Lavipharm Corp. manufactures and distributes pharmaceutical and cosmetic products. It develops drugs for the cardiology, central nervous system, gastrointestinal system, and dermatological treatment. The company was founded in 1979 and is located in East Windsor, NJ. | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
